These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34623418)
41. Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States. Inoue-Choi M; Christensen CH; Rostron BL; Cosgrove CM; Reyes-Guzman C; Apelberg B; Freedman ND JAMA Netw Open; 2020 Jun; 3(6):e206436. PubMed ID: 32492162 [TBL] [Abstract][Full Text] [Related]
42. Smoking worsens the prognosis in multiple sclerosis. Sundström P; Nyström L Mult Scler; 2008 Sep; 14(8):1031-5. PubMed ID: 18632778 [TBL] [Abstract][Full Text] [Related]
43. A 10-year prospective study of tobacco smoking and periodontal health. Bergström J; Eliasson S; Dock J J Periodontol; 2000 Aug; 71(8):1338-47. PubMed ID: 10972650 [TBL] [Abstract][Full Text] [Related]
44. A mindfulness group intervention in newly diagnosed persons with multiple sclerosis: A pilot study. Morrow SA; Riccio P; Vording N; Rosehart H; Casserly C; MacDougall A Mult Scler Relat Disord; 2021 Jul; 52():103016. PubMed ID: 34020388 [TBL] [Abstract][Full Text] [Related]
45. Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis. Sonder JM; Holman R; Knol DL; Bosma LV; Polman CH; Uitdehaag BM J Neurol Sci; 2013 Nov; 334(1-2):143-7. PubMed ID: 24018128 [TBL] [Abstract][Full Text] [Related]
46. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. Weiland TJ; Hadgkiss EJ; Jelinek GA; Pereira NG; Marck CH; van der Meer DM J Neurol Sci; 2014 Jan; 336(1-2):211-9. PubMed ID: 24290614 [TBL] [Abstract][Full Text] [Related]
47. The link between smoking status and co-morbid conditions in individuals with multiple sclerosis (MS). Newland P; Flick L; Salter A; Dixon D; Jensen MP Disabil Health J; 2017 Oct; 10(4):587-591. PubMed ID: 28351749 [TBL] [Abstract][Full Text] [Related]
49. Associations between smoking and walking, fatigue, depression, and health-related quality of life in persons with multiple sclerosis. Kahraman T; Ozdogar AT; Abasiyanik Z; Ozakbas S; Acta Neurol Belg; 2021 Oct; 121(5):1199-1206. PubMed ID: 32222910 [TBL] [Abstract][Full Text] [Related]
50. Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. Zajicek J; Ball S; Wright D; Vickery J; Nunn A; Miller D; Cano MG; McManus D; Mallik S; Hobart J; Lancet Neurol; 2013 Sep; 12(9):857-865. PubMed ID: 23856559 [TBL] [Abstract][Full Text] [Related]
51. Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29. Rosti-Otajärvi E; Hämäläinen P; Wiksten A; Hakkarainen T; Ruutiainen J Brain Behav; 2017 Jul; 7(7):e00725. PubMed ID: 28729932 [TBL] [Abstract][Full Text] [Related]
52. Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales. Tang CC; Soh SE; Boonstra F; Noffs G; Kolbe SC; Butzkueven H; Evans A; Van der Walt A Mult Scler Relat Disord; 2022 Feb; 58():103495. PubMed ID: 35085981 [TBL] [Abstract][Full Text] [Related]
53. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. McGuigan C; Hutchinson M J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):266-9. PubMed ID: 14742602 [TBL] [Abstract][Full Text] [Related]
54. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients? Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928 [TBL] [Abstract][Full Text] [Related]
55. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome. Leung S; Gallup D; Mahaffey KW; Cohen M; Antman EM; Goodman SG; Harrington RA; Langer A; Aylward P; Ferguson JJ; Califf RM; Am Heart J; 2008 Jul; 156(1):177-84. PubMed ID: 18585514 [TBL] [Abstract][Full Text] [Related]
56. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies. Zhu D; Chung HF; Pandeya N; Dobson AJ; Cade JE; Greenwood DC; Crawford SL; Avis NE; Gold EB; Mitchell ES; Woods NF; Anderson D; Brown DE; Sievert LL; Brunner EJ; Kuh D; Hardy R; Hayashi K; Lee JS; Mizunuma H; Giles GG; Bruinsma F; Tillin T; Simonsen MK; Adami HO; Weiderpass E; Canonico M; Ancelin ML; Demakakos P; Mishra GD PLoS Med; 2018 Nov; 15(11):e1002704. PubMed ID: 30481189 [TBL] [Abstract][Full Text] [Related]
57. The effect of smoking cessation on work disability risk: a longitudinal study analysing observational data as non-randomized nested pseudo-trials. Airaksinen J; Ervasti J; Pentti J; Oksanen T; Suominen S; Vahtera J; Virtanen M; Kivimäki M Int J Epidemiol; 2019 Apr; 48(2):415-422. PubMed ID: 30815682 [TBL] [Abstract][Full Text] [Related]
58. The association between tobacco smoking and depression and anxiety in people with multiple sclerosis: A systematic review. Vong V; Simpson-Yap S; Phaiju S; Davenport RA; Neate SL; Pisano MI; Reece JC Mult Scler Relat Disord; 2023 Feb; 70():104501. PubMed ID: 36621161 [TBL] [Abstract][Full Text] [Related]
59. A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study. Mitsikostas DD; Doskas T; Gkatzonis S; Fakas N; Maltezou M; Papadopoulos D; Gourgioti R; Mitsias P Adv Ther; 2021 Mar; 38(3):1536-1551. PubMed ID: 33528792 [TBL] [Abstract][Full Text] [Related]
60. Smoking cessation aids and strategies: a population-based survey of former and current smokers in Norway. Lund M; Lund I BMC Public Health; 2022 Mar; 22(1):631. PubMed ID: 35361172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]